BHC — Bausch Health Companies Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 885590 ·
Last close
$6.04
Market Cap
$2.26B
52W High
$8.00
52W Low
$4.33
ADV30
2,219,957
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 2,524,000,000 | 1,786,000,000 | 521,000,000 | -1,423,000,000 | 24,498,000,000 | 1,299,000,000 | 25,580,000,000 |
| Dec 2025 | 2,796,000,000 | 1,998,000,000 | 829,000,000 | -112,000,000 | 26,366,000,000 | 1,309,000,000 | 25,989,000,000 |
| Sep 2025 | 2,681,000,000 | 1,931,000,000 | 636,000,000 | 179,000,000 | 26,824,000,000 | 1,308,000,000 | 26,468,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,800,000,000
Investing CF
$-597,000,000
Financing CF
$-1,103,000,000
CapEx
$-407,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.96
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,832,000,000
Inventory
$1,602,000,000
Receivables
$2,263,000,000
ST Investments
—
EBIT TTM
$875,000,000
Pretax Income TTM
$-732,000,000
Interest Exp TTM
$1,607,000,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,853,000,192
EBITDA
$3,908,000,000
Free Cash Flow
$1,433,624,960
Enterprise Value
$22,114,584,576
Total Cash
$1,824,999,936
Total Debt
$20,778,999,808
Shares Out
373,990,561
Trailing EPS
$-2.94
Book Value
$-4.74
ROE
—
ROA
6.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,266,000,000 | 2,185,000,000 | 157,000,000 | 26,366,000,000 | 25,989,000,000 | -554,000,000 | 1,400,000,000 |
| Dec 2024 | 9,625,000,000 | 1,854,000,000 | -46,000,000 | 26,523,000,000 | 26,845,000,000 | -1,279,000,000 | 1,597,000,000 |
| Dec 2023 | 8,757,000,000 | 1,600,000,000 | -592,000,000 | 27,350,000,000 | 27,432,000,000 | -1,022,000,000 | 1,032,000,000 |
| Dec 2022 | 8,124,000,000 | 1,391,000,000 | -225,000,000 | 25,686,000,000 | 25,426,000,000 | -692,000,000 | -728,000,000 |
TTM Snapshot
Revenues TTM
$10,531,000,000
NetIncome TTM
$-1,208,000,000
OpCashFlow TTM
—
Assets (Latest)
$24,498,000,000
Forward EPS
$4.19
Max Pain — expiry 2026-10-16
max pain strike: $6.00 · spot: $6.04 · call oi: 15,065 · put oi: 4,649
Expected Move to 2026-10-16:
±$0.46
(7.62%) —
implied range
$5.58 –
$6.50
· ATM straddle on $6.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PBH | Prestige Consumer Healthcare Inc. | $2.27B | $47.87 | — |
| SLS | SELLAS Life Sciences Group, Inc. | $2.27B | $11.26 | — |
| NRIX | Nurix Therapeutics, Inc. | $2.30B | $22.21 | — |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | $39.60 | — |
| IMNM | Immunome Inc. | $2.19B | $19.31 | — |
News headlines (Yahoo Finance, 1h cache)
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
2026-10-06 11:00 · Yahoo
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
2026-09-30 11:29 · Yahoo
Best Value Stocks to Buy for September 22nd
2026-09-22 09:20 · Yahoo
Bausch Health (BHC) Expands Probiotic Skincare Bet To Six New Markets
2026-09-16 04:34 · Yahoo
Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets
2026-09-08 12:00 · Yahoo
Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia
2026-09-01 12:01 · Yahoo
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
2026-08-27 12:02 · Yahoo
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
2026-08-17 12:00 · Yahoo
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
2026-09-14 12:45 · Yahoo
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
2026-10-05 12:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.